|
US4021387A
(en)
|
1975-11-19 |
1977-05-03 |
President And Fellows Of Harvard College |
Eosinophilotactic tetrapeptides
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US4816449A
(en)
|
1984-08-09 |
1989-03-28 |
Immunetech Pharmaceuticals |
Immunotherapeutic anti-inflammatory peptide agents
|
|
US4613676A
(en)
|
1983-11-23 |
1986-09-23 |
Ciba-Geigy Corporation |
Substituted 5-amino-4-hydroxyvaleryl derivatives
|
|
ZA846192B
(en)
|
1984-08-09 |
1986-03-26 |
Merck Patent Gmbh |
Immunotherapeutic polypeptide agents
|
|
US5728680A
(en)
|
1987-12-30 |
1998-03-17 |
Cytoven J.V. |
Methods for normalizing numbers of lymphocytes
|
|
DK53291D0
(da)
|
1991-03-25 |
1991-03-25 |
Carlbiotech Ltd As |
Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
|
|
US5938117A
(en)
|
1991-04-24 |
1999-08-17 |
Aerogen, Inc. |
Methods and apparatus for dispensing liquids as an atomized spray
|
|
US6540154B1
(en)
|
1991-04-24 |
2003-04-01 |
Aerogen, Inc. |
Systems and methods for controlling fluid feed to an aerosol generator
|
|
US6629646B1
(en)
|
1991-04-24 |
2003-10-07 |
Aerogen, Inc. |
Droplet ejector with oscillating tapered aperture
|
|
US5277175A
(en)
|
1991-07-12 |
1994-01-11 |
Riggs John H |
Continuous flow nebulizer apparatus and method, having means maintaining a constant-level reservoir
|
|
GB9120005D0
(en)
|
1991-09-19 |
1991-11-06 |
Wellcome Found |
Method of administering phospholipid dispersions
|
|
US5355872B1
(en)
|
1992-03-04 |
1998-10-20 |
John H Riggs |
Low flow rate nebulizer apparatus and method of nebulization
|
|
US5284133A
(en)
|
1992-07-23 |
1994-02-08 |
Armstrong Pharmaceuticals, Inc. |
Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
|
|
US5329028A
(en)
|
1992-08-05 |
1994-07-12 |
Genentech, Inc. |
Carbohydrate-directed cross-linking reagents
|
|
HUT71860A
(en)
|
1992-08-27 |
1996-02-28 |
Deakin Res Ltd |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
|
JP3401005B2
(ja)
|
1992-12-11 |
2003-04-28 |
ユニバーシティ オブ フロリダ |
有害生物の防除のための材料および方法
|
|
US5559209A
(en)
|
1993-02-18 |
1996-09-24 |
The General Hospital Corporation |
Regulator regions of G proteins
|
|
US5497763A
(en)
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
|
JPH11512299A
(ja)
|
1995-09-06 |
1999-10-26 |
ライダー，スチーブン，エル． |
可変酸素濃度高流量噴霧器
|
|
US5823179A
(en)
|
1996-02-13 |
1998-10-20 |
1263152 Ontario Inc. |
Nebulizer apparatus and method
|
|
ES2140998B1
(es)
|
1996-05-13 |
2000-10-16 |
Univ Sevilla |
Procedimiento de atomizacion de liquidos.
|
|
US6126939A
(en)
|
1996-09-03 |
2000-10-03 |
Yeda Research And Development Co. Ltd. |
Anti-inflammatory dipeptide and pharmaceutical composition thereof
|
|
US6017735A
(en)
|
1997-01-23 |
2000-01-25 |
Marie Curie Cancer Care |
Materials and methods for intracellular transport and their uses
|
|
US20030113271A1
(en)
|
1997-01-29 |
2003-06-19 |
University Technology Corporation |
Formulations for pulmonary delivery
|
|
IT1291122B1
(it)
|
1997-03-28 |
1998-12-29 |
Sar Spa |
Micropompa per la nebulizzazione di fluidi con valvola dosatrice perfezionata
|
|
US6096707A
(en)
|
1997-07-11 |
2000-08-01 |
Biotie Therapies Ltd. |
Integrin binding peptide and use thereof
|
|
US6044841A
(en)
|
1997-08-29 |
2000-04-04 |
1263152 Ontario Inc. |
Breath actuated nebulizer with valve assembly having a relief piston
|
|
US6041776A
(en)
|
1998-05-14 |
2000-03-28 |
Briggs, Iii; Stephen W. |
Medical nebulization device
|
|
US6354516B1
(en)
|
1999-11-02 |
2002-03-12 |
Aradigm Corporation |
Pore structures for reduced pressure aerosolization
|
|
SE9900369D0
(sv)
|
1999-02-04 |
1999-02-04 |
Siemens Elema Ab |
Ultrasonic nebuliser
|
|
US6328030B1
(en)
|
1999-03-12 |
2001-12-11 |
Daniel E. Kidwell |
Nebulizer for ventilation system
|
|
EP1076091A1
(en)
*
|
1999-08-09 |
2001-02-14 |
Universite Catholique De Louvain |
Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds
|
|
WO2002009798A1
(en)
|
2000-08-02 |
2002-02-07 |
Research Development Foundation |
Jet nebulizer assembly for home administration of drugs in aerosols
|
|
US20020077283A1
(en)
|
2000-09-08 |
2002-06-20 |
Sessa William C. |
Caveolin peptides and their use as therapeutics
|
|
US6732944B2
(en)
|
2001-05-02 |
2004-05-11 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
|
GB0119852D0
(en)
|
2001-08-15 |
2001-10-10 |
Univ York |
Baculovirus
|
|
US7360536B2
(en)
|
2002-01-07 |
2008-04-22 |
Aerogen, Inc. |
Devices and methods for nebulizing fluids for inhalation
|
|
WO2003059424A1
(en)
|
2002-01-15 |
2003-07-24 |
Aerogen, Inc. |
Methods and systems for operating an aerosol generator
|
|
WO2003086278A2
(en)
|
2002-04-05 |
2003-10-23 |
Board Of Regents, The University Of Texas System |
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
|
|
EP1501479A1
(en)
|
2002-05-07 |
2005-02-02 |
Nektar Therapeutics |
Capsules for dry powder inhalers and methods of making and using same
|
|
US20040175384A1
(en)
|
2003-12-12 |
2004-09-09 |
Mohapatra Shyam S. |
Protein kinase C as a target for the treatment of respiratory syncytial virus
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20070207158A1
(en)
|
2003-06-17 |
2007-09-06 |
Harrison Roger G |
Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
EP1734938B1
(en)
|
2004-03-26 |
2012-06-20 |
Universita' Degli Studi Di Parma |
Insulin highly respirable microparticles
|
|
PT1765397E
(pt)
|
2004-05-25 |
2013-02-04 |
Tactic Pharma Llc |
Anticorpos inibidores que se ligam ao complexo ativador plasminogénico do tipo uroquinasa (upa) e seu receptor (upar)
|
|
EP1896662B1
(en)
|
2005-05-25 |
2014-07-23 |
AeroGen, Inc. |
Vibration systems and methods
|
|
TWI299993B
(en)
|
2005-12-15 |
2008-08-21 |
Dev Center Biotechnology |
Aqueous inhalation pharmaceutical composition
|
|
US8058227B2
(en)
|
2006-10-03 |
2011-11-15 |
Medical University Of South Carolina |
Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
|
|
JP2010506860A
(ja)
*
|
2006-10-19 |
2010-03-04 |
アンジオケム，インコーポレーテッド |
Ｐ−糖タンパク質機能を刺激するための化合物およびその使用
|
|
US20090068258A1
(en)
|
2007-08-28 |
2009-03-12 |
Lisanti Michael P |
Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy
|
|
EP2220115A2
(en)
|
2007-12-13 |
2010-08-25 |
Glaxo Group Limited |
Polypeptides, antibody variable domains & antagonists
|
|
WO2009111625A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Board Of Regents, The University Of Texas System |
Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis
|
|
US20110171193A1
(en)
|
2008-06-12 |
2011-07-14 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating pulmonary hypertension
|
|
SG193209A1
(en)
|
2008-09-10 |
2013-09-30 |
Genentech Inc |
Methods for inhibiting ocular angiogenesis
|
|
EP2349314B1
(en)
|
2008-10-21 |
2013-02-27 |
Baxter International Inc. |
Lyophilized recombinant vwf formulations
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
SG176053A1
(en)
|
2009-05-15 |
2011-12-29 |
Intermune Inc |
Methods of treating hiv patients with anti-fibrotics
|
|
KR20120110090A
(ko)
|
2009-09-28 |
2012-10-09 |
에프. 호프만-라 로슈 리미티드 |
Ｃ형 간염 바이러스 복제의 신규한 마크로시클릭 저해제
|
|
DK2533761T3
(da)
|
2010-02-11 |
2019-06-24 |
Ablynx Nv |
Fremgangsmåder og sammensætninger til fremstilling af aerosoler
|
|
WO2012061828A2
(en)
*
|
2010-11-05 |
2012-05-10 |
The Regents Of The University Of California |
Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
|
|
CN107099581B
(zh)
|
2012-03-27 |
2021-07-13 |
弗·哈夫曼-拉罗切有限公司 |
预测、诊断和治疗特发性肺纤维化的方法
|
|
WO2013184482A1
(en)
|
2012-06-04 |
2013-12-12 |
Yale University |
Method of treating and preventing ocular angiogenesis
|
|
US10441536B2
(en)
|
2013-03-13 |
2019-10-15 |
Actavis Group Ptc Ehf |
Micronized colistimethane sodium pharmaceutical compositions
|
|
CN110201144B
(zh)
|
2013-03-15 |
2024-01-02 |
得克萨斯州大学系统董事会 |
用Nutlin-3a和肽抑制肺纤维化
|
|
CN104274827B
(zh)
|
2013-07-01 |
2020-07-14 |
上海贺普药业股份有限公司 |
贺普拉肽的制剂
|
|
PE20160789A1
(es)
|
2013-11-04 |
2016-08-17 |
Univ Texas |
Composiciones y metodos para admistracion de una enzima a las vias respiratorias de un sujeto
|
|
WO2015080943A1
(en)
|
2013-11-26 |
2015-06-04 |
Yale University |
Novel cell-penetrating compositions and methods using same
|
|
WO2015080980A2
(en)
*
|
2013-11-26 |
2015-06-04 |
E&B Technologies Llc |
Treatment of autoimmune and/or inflammatory disease using novel caveolin modulators
|
|
EP4056194A1
(en)
|
2015-02-27 |
2022-09-14 |
Board of Regents, The University of Texas System |
Polypeptide therapeutics and uses thereof
|
|
CN107216394B
(zh)
*
|
2017-06-21 |
2020-10-09 |
江南大学 |
一种小窝蛋白-1脚手架区融合多肽的制备方法及其应用
|
|
US20190224243A1
(en)
|
2018-01-25 |
2019-07-25 |
Musc Foundation For Research Development |
Enhancement of the Beneficial Effects of Mesenchymal Stem Cell Treatment by the Caveolin-1 Scaffolding Domain Peptide and Subdomains
|
|
US12280088B2
(en)
|
2018-09-10 |
2025-04-22 |
Board Of Regents, The University Of Texas System |
Dry powder formulation of caveolin-1 peptides and methods of use thereof
|
|
EP3849580A4
(en)
|
2018-09-10 |
2022-06-15 |
Lung Therapeutics, Inc. |
MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THEIR USE IN THE TREATMENT OF FIBROSIS
|
|
US20240082342A1
(en)
|
2018-11-21 |
2024-03-14 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for increasing lung cell viability
|
|
WO2020106922A1
(en)
|
2018-11-21 |
2020-05-28 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for acute and chronic airway and alveolar diseases
|
|
US20220160814A1
(en)
|
2019-03-11 |
2022-05-26 |
Lung Therapeutics, Inc. |
Compositions and methods for protecting type 2 alveolar epithelial cells (aec2)
|
|
US12097222B2
(en)
|
2019-06-06 |
2024-09-24 |
Spiritus Therapeutics, Inc. |
Methods for attenuating viral infection and for treating lung injury
|
|
CN111671886B
(zh)
|
2020-03-05 |
2022-11-15 |
上海甘翼生物医药科技有限公司 |
一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途
|
|
US20230159608A1
(en)
|
2020-04-21 |
2023-05-25 |
Lung Therapeutics, Inc. |
Modified peptide fragments of cav-1 protein and uses thereof
|
|
US20230226149A1
(en)
|
2020-06-19 |
2023-07-20 |
Lung Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of pathogen-induced lung injury
|
|
EP4297768A4
(en)
|
2021-02-25 |
2025-01-15 |
Lung Therapeutics, LLC |
Biomarkers for the treatment of interstitial lung disease
|
|
US12449810B2
(en)
|
2021-03-01 |
2025-10-21 |
The Boeing Company |
Autonomous maneuver generation to mate connectors
|
|
WO2022266410A1
(en)
|
2021-06-17 |
2022-12-22 |
Lung Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of post-acute covid-19
|
|
JP2024539242A
(ja)
|
2021-10-22 |
2024-10-28 |
ラング セラピューティクス，エルエルシー |
慢性腎疾患の治療のための改変カベオリン－１ペプチド
|